Details for Patent: 8,113,199
✉ Email this page to a colleague
Which drugs does patent 8,113,199 protect, and when does it expire?
Patent 8,113,199 protects ARNUITY ELLIPTA and is included in one NDA.
Protection for ARNUITY ELLIPTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-six patent family members in twenty-one countries.
Summary for Patent: 8,113,199
| Title: | Counter for use with a medicament dispenser |
| Abstract: | There is provided a dose counter for use with a medicament dispenser. The dose counter comprises a first count wheel arranged to rotate about a first axis of rotation, the first count wheel including a set of primary drive teeth arranged annularly thereon for drivable rotation of the first count wheel about the first axis of rotation; a second count wheel arranged to rotate about the first axis of rotation, the second count wheel including a set of secondary drive teeth arranged annularly thereon; and a kick wheel arranged to rotate about a second axis of rotation offset from the first axis of rotation, the kick wheel including a set of kick teeth arranged annularly thereon and in meshed relationship with the set of secondary drive teeth of the second count wheel such that rotary motion of the kick wheel results in rotary motion of the second count wheel. The first count wheel further includes a fixed index tooth arranged for intermittent meshing with the kick teeth of the kick wheel such that rotary motion of the kick wheel results from rotary motion of the first count wheel only when the intermittent meshing occurs. |
| Inventor(s): | Augustyn; Stephen Edward (Milton Keynes, GB), Harvey; Stephen James (Ware, GB) |
| Assignee: | Glaxo Group Limited (Greenford, Middlesex, GB) |
| Application Number: | 10/597,551 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,113,199 |
|
Patent Claim Types: see list of patent claims | Use; |
Recent additions to Drugs Protected by US Patent 8,113,199
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER | 205625 | May 17, 2018 | RX | Yes | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER | 205625 | Aug 20, 2014 | RX | Yes | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 8,113,199
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER;INHALATION | 205625-003 | May 17, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER;INHALATION | 205625-002 | Aug 20, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,113,199
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0403394.0 | Feb 16, 2004 |
| United Kingdom | 0418264.8 | Aug 16, 2004 |
| PCT Information | |||
| PCT Filed | February 15, 2005 | PCT Application Number: | PCT/GB2005/000531 |
| PCT Publication Date: | September 01, 2005 | PCT Publication Number: | WO2005/079727 |
International Family Members for US Patent 8,113,199
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005215216 | ⤷ Try a Trial | |||
| Brazil | PI0507714 | ⤷ Try a Trial | |||
| Canada | 2555347 | ⤷ Try a Trial | |||
| China | 1998010 | ⤷ Try a Trial | |||
| Cyprus | 1114641 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
